PMC:7199903 / 4170-4588 JSONTXT 19 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T671 0-2 TO denotes To
T672 3-10 VB denotes resolve
T673 11-14 DT denotes the
T674 15-28 JJ denotes site-specific
T675 29-42 NN denotes glycosylation
T676 43-45 IN denotes of
T677 46-49 DT denotes the
T678 50-60 NN denotes SARS-CoV-2
T679 61-62 NN denotes S
T680 63-70 NN denotes protein
T681 71-74 CC denotes and
T682 75-84 VB denotes visualize
T683 85-88 DT denotes the
T684 89-101 NN denotes distribution
T685 102-104 IN denotes of
T686 105-115 NNS denotes glycoforms
T687 116-122 IN denotes across
T688 123-126 DT denotes the
T689 127-134 NN denotes protein
T690 135-142 NN denotes surface
T691 142-143 -COMMA- denotes ,
T692 144-146 PRP denotes we
T693 147-156 VBD denotes expressed
T694 157-160 CC denotes and
T695 161-169 VBN denotes purified
T696 170-175 CD denotes three
T697 176-186 JJ denotes biological
T698 187-197 NNS denotes replicates
T699 198-200 IN denotes of
T700 201-212 JJ denotes recombinant
T701 213-220 JJ denotes soluble
T702 221-229 NN denotes material
T703 230-232 IN denotes in
T704 233-235 DT denotes an
T705 236-245 JJ denotes identical
T706 246-252 NN denotes manner
T707 253-255 TO denotes to
T708 256-260 DT denotes that
T709 261-266 WDT denotes which
T710 267-270 VBD denotes was
T711 271-275 VBN denotes used
T712 276-278 TO denotes to
T713 279-285 VB denotes obtain
T714 286-289 DT denotes the
T715 290-305 JJ denotes high-resolution
T716 306-319 NN denotes cryo–electron
T717 320-330 NN denotes microscopy
T718 331-332 -LRB- denotes (
T719 332-339 NN denotes cryo-EM
T720 339-340 -RRB- denotes )
T721 341-350 NN denotes structure
T722 350-351 -COMMA- denotes ,
T723 352-358 IN denotes albeit
T724 359-366 IN denotes without
T725 367-368 DT denotes a
T726 369-386 NN denotes glycan-processing
T727 387-395 NN denotes blockade
T728 396-401 VBG denotes using
T729 402-413 NN denotes kifunensine
T730 414-415 -LRB- denotes (
T731 415-416 CD denotes 4
T732 416-417 -RRB- denotes )
R673 T681 T671 arg1Of and,To
R674 T693 T671 modOf expressed,To
R675 T692 T672 arg1Of we,resolve
R676 T675 T672 arg2Of glycosylation,resolve
R677 T675 T673 arg1Of glycosylation,the
R678 T675 T674 arg1Of glycosylation,site-specific
R679 T675 T676 arg1Of glycosylation,of
R680 T680 T676 arg2Of protein,of
R681 T680 T677 arg1Of protein,the
R682 T680 T678 arg1Of protein,SARS-CoV-2
R683 T680 T679 arg1Of protein,S
R684 T672 T681 arg1Of resolve,and
R685 T682 T681 arg2Of visualize,and
R686 T692 T682 arg1Of we,visualize
R687 T684 T682 arg2Of distribution,visualize
R688 T684 T683 arg1Of distribution,the
R689 T684 T685 arg1Of distribution,of
R690 T686 T685 arg2Of glycoforms,of
R691 T684 T687 arg1Of distribution,across
R692 T690 T687 arg2Of surface,across
R693 T690 T688 arg1Of surface,the
R694 T690 T689 arg1Of surface,protein
R695 T693 T691 arg1Of expressed,","
R696 T692 T693 arg1Of we,expressed
R697 T698 T693 arg2Of replicates,expressed
R698 T698 T694 arg1Of replicates,and
R699 T698 T695 arg2Of replicates,purified
R700 T698 T696 arg1Of replicates,three
R701 T698 T697 arg1Of replicates,biological
R702 T698 T699 arg1Of replicates,of
R703 T702 T699 arg2Of material,of
R704 T702 T700 arg1Of material,recombinant
R705 T702 T701 arg1Of material,soluble
R706 T693 T703 arg1Of expressed,in
R707 T706 T703 arg2Of manner,in
R708 T706 T704 arg1Of manner,an
R709 T706 T705 arg1Of manner,identical
R710 T693 T707 arg1Of expressed,to
R711 T708 T707 arg2Of that,to
R712 T708 T709 arg1Of that,which
R713 T708 T710 arg1Of that,was
R714 T711 T710 arg2Of used,was
R715 T708 T711 arg2Of that,used
R716 T713 T711 arg3Of obtain,used
R717 T713 T712 arg1Of obtain,to
R718 T708 T713 arg1Of that,obtain
R719 T721 T713 arg2Of structure,obtain
R720 T721 T714 arg1Of structure,the
R721 T717 T715 arg1Of microscopy,high-resolution
R722 T717 T716 arg1Of microscopy,cryo–electron
R723 T721 T717 arg1Of structure,microscopy
R724 T717 T718 arg1Of microscopy,(
R725 T719 T718 arg2Of cryo-EM,(
R726 T720 T718 arg3Of ),(
R727 T711 T722 arg1Of used,","
R728 T724 T723 arg1Of without,albeit
R729 T711 T724 arg1Of used,without
R730 T727 T724 arg2Of blockade,without
R731 T727 T725 arg1Of blockade,a
R732 T727 T726 arg1Of blockade,glycan-processing
R733 T727 T728 arg1Of blockade,using
R734 T729 T728 arg2Of kifunensine,using
R735 T729 T730 arg1Of kifunensine,(
R736 T731 T730 arg2Of 4,(
R737 T732 T730 arg3Of ),(